Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Press Room Contact Us Sitemap Sign In Register
Link to Homepage About BrightFocus
BrightFocus
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research


Sign up for Email Notifications
If you would like to be notified when funding or meeting opportunities are announced please click on the link below.

Sign up for new announcements.

Please add ResearchGrants@BrightFocus.org to your institution’s white list to insure that the notification is not blocked by your organization’s SPAM filters.

This email list is not sold or distributed, and serves only as an annual reminder of the availability of research support through the BrightFocus Foundation (www.brightfocus.org). Please follow instructions on the notification emails for removal requests.

 
 
BrightFocus Research Grants Funding
Grant Funding for Alzheimer's Research
Grant Funding for Macular Degeneration Research
Grant Funding for Glaucoma Research
 

 

National Glaucoma Research
Completed Award

Donald J. Zack, M.D., Ph.D.

Johns Hopkins University
Baltimore, MD, United States

Title: Role of a Protein Kinase in Retinal Ganglion Cell Degeneration in Glaucoma
Non-Technical Title: A Novel Target in Promoting Retinal Ganglion Cell Survival in Glaucomain Glaucoma

Acknowledgements: Dr. Yang (the original PI) was the recipient of the Dr. Douglas H. Johnson award for glaucoma research
Duration: July 1, 2012 - June 30, 2014
Award Type: Standard
Award Amount: $100,000

Summary:

The research proposed in this application will directly determine the potential value of a new protein target in the treatment of vision loss in glaucoma. In addition, Drs. Yang, Zack, and colleagues will evaluate a drug candidate that can block this target for its potential to preserve vision in a rodent model of glaucoma.

The research grant was originally awarded to Zhiyong Yang, M.D., Ph.D. and transferred to Dr. Zack in August of 2013 when Dr. Yang left Johns Hopkins.

Details:

Dr. Zack and colleagues will use a mouse model of glaucoma to evaluate whether a protein is important in the death of retinal ganglion cells and whether the cells can still relay visual information to the brain. Moreover, these researchers will test whether a compound specifically blocking the protein can increase retinal ganglion cell survival in an animal model of glaucoma. The protein was identified by previous studies by this same research group, but its potential function in glaucoma was not assessed. The completion of this study may help to identify a new drug candidate for treatment of glaucoma and may determine how this protein plays a role in glaucoma.

Publications:

Welsbie DS, Yang Z, Ge Y, Mitchell KL, Zhou X, Martin SE, Berlinicke CA, Hackler L Jr, Fuller J, Fu J, Cao LH, Han B, Auld D, Xue T, Hirai S, Germain L, Simard-Bisson C, Blouin R, Nguyen JV, Davis CH, Enke RA, Boye SL, Merbs SL, Marsh-Armstrong N, Hauswirth WW, DiAntonio A, Nickells RW, Inglese J, Hanes J, Yau KW, Quigley HA, Zack DJ. Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death. Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):4045-50. doi: 10.1073/pnas.1211284110. Epub 2013 Feb 19. PubMed Icon Google Scholar Icon